title: Pharmaceutical approval update.
abstract: Bosutinib (Bosulif) tablets for chronic myelogenous leukemia; linaclotide (Linzess) for irritable bowel syndrome/constipation and chronic idiopathic constipation; and regorefenib (Stivarga) tablets for metastatic colorectal cancer.
authors.forename: Marvin M
authors.initials: MM
authors.lastname: Goldenberg